Navigation Links
Savient Pharmaceuticals Announces Expected Availability of KRYSTEXXA™ for Prescription and Reports Third Quarter 2010 Financial Results
Date:11/4/2010

EAST BRUNSWICK, N.J., Nov. 4, 2010 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that it plans to commence shipments of KRYSTEXXA™ to specialty distributors on November 30, 2010. KRYSTEXXA, a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy, is then expected to be commercially available for prescription as of December 1, 2010. In conjunction with the commercial availability of KRYSTEXXA, Savient plans to launch its reimbursement and pharmacovigilance hotline services on November 22, 2010 for use by prescribers and patients. Savient expects to announce the pricing for KRYSTEXXA at the time it commences commercial distribution.

"The commercial availability of KRYSTEXXA marks another significant milestone for both patients and the company as it is the first FDA approved therapy that addresses a significant unmet medical need in the treatment of chronic gout in adult patients refractory to conventional therapy," said Paul Hamelin R.Ph., President of Savient Pharmaceuticals.  "We believe that making KRYSTEXXA commercially available is a significant step towards realizing our mission of transforming the lives of the patients in the U.S. suffering from this crippling disease.  These patients have been waiting for decades for a therapy that gives them hope of reversing this severely debilitating disease."

Savient also today reported financial results for the three and nine months ended September 30, 2010. The Company ended the quarter with $78.1 million in cash and short-term investments, a decrease of $10.9 million for the quarter and $30.1 million since December 31, 2009.  As of November 2, 2010, the Company had $75.7 million in cash and short-term investments.

For the third quarter of 2010, the Company had a net loss of $5
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Savient Pharmaceuticals to Hold Third Quarter 2010 Financial Results Conference Call on Friday, November 5, 2010
2. Savient Pharmaceuticals to Hold Conference Call on October 26, 2010 at 8:30 a.m. Eastern Time
3. Savient Pharmaceuticals Provides Update on Strategic Alternatives Process
4. Savient Pharmaceuticals Announces Dismissal of Class Action Lawsuit
5. Savient Pharmaceuticals To Hold First Quarter 2010 Results
6. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
7. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
10. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
11. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 DePuy ... agreement with Radlink, Inc., an emerging global leader ... image guidance with its hip replacement systems. The ... to help improve patient outcomes, increase patient satisfaction ... with the 81st annual meeting of the American ...
(Date:3/26/2015)... CAMBRIDGE, Mass. , March 26, 2015 ... today announced that it will present preclinical ... pipeline at the 2015 American Association for ... April 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia. The ... antibody engineering and nanoliposomal technology platforms, as ...
(Date:3/26/2015)... SANTA CLARA , Kalifornien, 26. März ... neue Veranstaltung Cellworld 2015, die sich speziell ... Bioprozesstechnologien richtet, an. Die zweitägige ... bis 22. September 2015 im Hyatt Regency ... statt. In diesem Forum werden führende ...
Breaking Medicine Technology:DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 2DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 3Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 2Merrimack to Highlight Extensive Oncology Pipeline at the 2015 American Association for Cancer Research Annual Meeting 3Finesse Solutions kündigt Cellworld 2015 an 2
(Date:3/26/2015)... 26, 2015 BioPlus Specialty ... innovative specialty pharmacies, announces the promotion of Sharon ... President of Pharmaceutical Relations. In this position, Ferrer ... our pharmaceuticals partners and providing key leadership in ... BioPlus’ expansion. , “Over the past seven ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... the Patients’ Access to Treatments Act (PATA) that ... week by Reps. David B. McKinley (R-WV) and ... limit cost-sharing requirements for medications placed in a ... by reducing patients’ out-of-pocket expenses. , This legislation ...
(Date:3/26/2015)... Documentation topped the list of ... Living facilities during 2014, despite the introduction of ... The survey queried Administrators, Directors of Nursing, ... and the variety of other interested parties who ... http://www.harmony-healthcare.com ) or participate in the company’s many ...
(Date:3/26/2015)... CRN International took the podium this week at ... achievement of jobseekers from five statewide locations as part ... , The program, called Platform to Employment and being ... the Connecticut Department of Labor, takes active steps to ... them at appropriate companies. CRN, a 40-year-old radio marketing ...
(Date:3/26/2015)... 2015 Zane Benefits, the leader in ... new eBook, “The Comprehensive Guide To Interviewing For Your ... the most important aspect of the hiring process. Many ... the right way, possibly resulting in thousands of dollars ... undertaking, yet it’s essential to the success of your ...
Breaking Medicine News(10 mins):Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2Health News:Harmony Healthcare International Releases 2015 Post Acute Care Trends Report 2Health News:Harmony Healthcare International Releases 2015 Post Acute Care Trends Report 3Health News:CRN International Shows Support For Groundbreaking Connecticut Program To Aid The Unemployed 2Health News:Zane Benefits Announces: New eBook: The Comprehensive Guide To Interviewing For Your Small Business 2
... to Decrease Growing Global Breast ... Cancer Incidence, Mortality Rates, WASHINGTON, March ... Susan G. Komen for the Cure (R) Global Promise Fund ... life-saving,work and outline its new strategy of funding culturally sensitive,sustainable ...
... Corporation (Nasdaq: PRSC ) today announced that it ... its common stock on Form S-3,with the Securities and ... the proposed shelf registration statement immediately,following the filing of ... Ended,December 31, 2007; however, it has no immediate plans ...
... March 12 With the cost of,medical ... Deloitte Center for Health,Solutions finds that better ... can dramatically improve care and drastically reduce,cost., ... Enabled Care at Home,",( http://www.deloitte.com/us/connectedcareathome ) promotes ...
... /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. (TSX: PMD; ... it has completed its previously announced debenture financing ... Ltd. The gross proceeds of the financing totaled ... corporate expenses, with a,focus on the Company,s appeal ...
... for arthritis pain or other conditions while taking aspirin ... aspirins ability to act as an anti-platelet agent, researchers ... a cohort of patients seen by physicians at two ... identified as taking both aspirin and ibuprofen (a nonsteroidal ...
... Lighthouse International has been is,a leader in serving people ... -- for 103 years., People who are legally blind ... the proper education and training., The news that Lt. ... sends an important message that people with vision loss can,achieve ...
Cached Medicine News:Health News:First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide 2Health News:First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide 3Health News:Providence Service Corporation Announces Intent to File a Common Stock Shelf Registration Statement 2Health News:Deloitte's 'Connected Care' Model Promotes Technologically Enabled In-Home Health Care, Projects Future Health Care Savings in the Billions 2Health News:Deloitte's 'Connected Care' Model Promotes Technologically Enabled In-Home Health Care, Projects Future Health Care Savings in the Billions 3Health News:PreMD Inc. Completes Debenture Financing 2Health News:PreMD Inc. Completes Debenture Financing 3Health News:Ibuprofen destroys aspirin's positive effect on stroke risk 2Health News:Ibuprofen destroys aspirin's positive effect on stroke risk 3
Plus cylinders only trial lens set....
Magnets move the color disks, Protects Disks from fingerprints, Keeps all the disks in one place, Clear glass insures accurate color perception, Makes Color testing fun....
Opti-Free Express multi-purpose disinfecting solution lasting comfort No Rub formula provides triple action protection for your contact lenses....
Grafton Trial Frame...
Medicine Products: